294 related articles for article (PubMed ID: 8906022)
1. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy.
Gallie BL; Budning A; DeBoer G; Thiessen JJ; Koren G; Verjee Z; Ling V; Chan HS
Arch Ophthalmol; 1996 Nov; 114(11):1321-8. PubMed ID: 8906022
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
Murphree AL; Villablanca JG; Deegan WF; Sato JK; Malogolowkin M; Fisher A; Parker R; Reed E; Gomer CJ
Arch Ophthalmol; 1996 Nov; 114(11):1348-56. PubMed ID: 8906025
[TBL] [Abstract][Full Text] [Related]
3. Chemoreduction in the initial management of intraocular retinoblastoma.
Shields CL; De Potter P; Himelstein BP; Shields JA; Meadows AT; Maris JM
Arch Ophthalmol; 1996 Nov; 114(11):1330-8. PubMed ID: 8906023
[TBL] [Abstract][Full Text] [Related]
4. Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy.
Greenwald MJ; Strauss LC
Ophthalmology; 1996 Dec; 103(12):1989-97. PubMed ID: 9003332
[TBL] [Abstract][Full Text] [Related]
5. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
[TBL] [Abstract][Full Text] [Related]
6. Chemoreduction for unilateral retinoblastoma.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
[TBL] [Abstract][Full Text] [Related]
7. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
8. Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation.
Chan HS; DeBoer G; Thiessen JJ; Budning A; Kingston JE; O'Brien JM; Koren G; Giesbrecht E; Haddad G; Verjee Z; Hungerford JL; Ling V; Gallie BL
Clin Cancer Res; 1996 Sep; 2(9):1499-508. PubMed ID: 9816326
[TBL] [Abstract][Full Text] [Related]
9. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma.
Kingston JE; Hungerford JL; Madreperla SA; Plowman PN
Arch Ophthalmol; 1996 Nov; 114(11):1339-43. PubMed ID: 8906024
[TBL] [Abstract][Full Text] [Related]
10. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
11. Bilateral macular retinoblastoma managed by chemoreduction and chemothermotherapy.
Shields JA; Shields CL; De Potter P; Needle M
Arch Ophthalmol; 1996 Nov; 114(11):1426-7. PubMed ID: 8906043
[No Abstract] [Full Text] [Related]
12. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
[TBL] [Abstract][Full Text] [Related]
13. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
[TBL] [Abstract][Full Text] [Related]
14. [Results of combined chemotherapy and local ophtalmic therapy for intraocular retinoblastoma].
Balwierz W; Pietrys D; Romanowska-Dixon B; Kobylarz J; Pawińska-Wasikowska K; Moryl-Bujakowska A
Przegl Lek; 2010; 67(6):404-8. PubMed ID: 21344770
[TBL] [Abstract][Full Text] [Related]
15. Management and outcome of retinoblastoma with vitreous seeds.
Manjandavida FP; Honavar SG; Reddy VA; Khanna R
Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
[TBL] [Abstract][Full Text] [Related]
16. Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma.
Wilson MW; Haik BG; Liu T; Merchant TE; Rodriguez-Galindo C
Am J Ophthalmol; 2005 Sep; 140(3):397-406. PubMed ID: 16138999
[TBL] [Abstract][Full Text] [Related]
17. Systemic chemotherapy as a new conservative treatment for intraocular retinoblastoma.
Yanagisawa T
Int J Clin Oncol; 2004 Feb; 9(1):13-24. PubMed ID: 15162821
[TBL] [Abstract][Full Text] [Related]
18. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.
Künkele A; Jurklies C; Wieland R; Lohmann D; Bornfeld N; Eggert A; Schulte JH
Br J Ophthalmol; 2013 Oct; 97(10):1277-83. PubMed ID: 23863458
[TBL] [Abstract][Full Text] [Related]
19. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
[TBL] [Abstract][Full Text] [Related]
20. Preliminary results of primary chemotherapy in retinoblastoma.
Bornfeld N; Schüler A; Bechrakis N; Henze G; Havers W
Klin Padiatr; 1997; 209(4):216-21. PubMed ID: 9293453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]